Search

everythinglearnresearchcommunity

for

Search:↓

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

Cyclodextrins improve finasteride's solubility and bioavailability for hair loss treatment.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

Hair growth is influenced by factors like genetics and nutrition, and more research is needed to understand hair loss and growth mechanisms.

Non-immune factors play a significant role in alopecia areata.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Mice with autoimmune hair loss showed signs of heart problems.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

Stress hormones like cortisol may trigger psoriasis flare-ups.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Low doses of BPA can increase prostate growth and change hormone levels in adult rats.

Ketoconazole increases finasteride's effectiveness and lifespan in the body.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Iron oxide nanoparticles improve skin penetration and drug release for hair loss treatment.

Estrogens are key for bone growth spurts in both boys and girls and affect growth into adulthood.

Reduced androgens linked to kinky hair disorder and hair loss; 5a-reductase inhibitors may help.

The main enzyme found in pubic skin that could be targeted to treat excessive hair growth is 5 alpha-R2.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Effective symptom management in IBD improves quality of life and prevents complications.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Testosterone is crucial for development, growth, and various body functions in mammals.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

Iron deficiency might contribute to hair loss in women.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.